Sean Spector, MD
Undefined Physician Type (Specify) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 8
- 3 carriers
- Offices
- 7
Offices
7 locations · County of Santa Clara · Multicare Health System
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
8 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Spector’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
8 of 8 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
State licence records
2 licences
- New Jersey 25MA10545100Medical Doctor · since 2019 · expires 2023-06-30InactiveNo board action on this licenceCheck it with the state
- Texas BP10052645Physician-in-Training Permit · since 2015 · expires 2019-06-30Permit TerminatedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of the uterus | 1-10 | None |
Medicaid work
$175,775 in 2024
Medicaid paid $175,775 for 3,971 billed services this clinician did in 2024, up to 87 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 338 | $175,028 |
| Return visit (30+ min) | 599 | $356 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 215 | $142 |
| Short return visit (20+ min) | 221 | $119 |
| Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique | 45 | $62 |
| Short return visit | 18 | $36 |
| Service | 13 | $32 |
| Pain severity quantified; no pain present (COA) (ONC) | 116 | $0 |
| Medication list documented in medical record (COA) | 671 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 448 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 195 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 228 | $0 |
| 2024 | 3,971 | 17 | 87 | $175,775 |
| 2023 | 1,322 | 10 | 39 | $186,979 |
| 2022 | 146 | 6 | 40 | $23,047 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 387 | $186,673 |
| Return visit (30+ min) | 373 | $144 |
| Short return visit (20+ min) | 219 | $134 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 103 | $29 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 52 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 65 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 16 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 78 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 15 | $0 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 14 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 46 | $22,911 |
| Return visit (30+ min) | 29 | $69 |
| Short return visit (20+ min) | 15 | $68 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 15 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 21 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 20 | $0 |
Drugs they prescribed that Part D paid
$80,346
Pharmacies billed $80,346 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
153 generic and 84 brand-name prescriptions · $80,346 in drug cost · 62 antibiotic prescriptions to 29 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gemtesa | 44 | $53,042 | $1,206 |
| Myrbetriq | 11 | $13,748 | $1,250 |
| Premarin | 16 | $6,292 | $393 |
| Estradiol | 60 | $3,380 | $56 |
| Nitrofurantoin Mono-Macro | 24 | $613 | $26 |
See all 6 drugs
| Gemtesa | 44 | $53,042 | $1,206 |
| Myrbetriq | 11 | $13,748 | $1,250 |
| Premarin | 16 | $6,292 | $393 |
| Estradiol | 60 | $3,380 | $56 |
| Nitrofurantoin Mono-Macro | 24 | $613 | $26 |
| Cephalexin | 17 | $65 | $4 |
Year by year
| 2024 | 237 | 75 | None | 35% | $80,346 |
| 2023 | 166 | 56 | None | 46% | $65,774 |
| 2022 | 151 | 72 | None | 26% | $41,728 |
| 2021 | 218 | 103 | 7% (16) | None | $39,607 |
| 2020 | 159 | 98 | 12% (19) | None | $32,375 |
| 2019 | 97 | 55 | None | None | $13,147 |
| 2018 | 14 | None | None | None | $822 |
| 2017 | 23 | 13 | None | None | $148 |
| 2016 | 62 | 12 | 0% (0) | None | $3,152 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Gemtesa | 33 | $37,571 | $1,139 |
| Premarin | 23 | $9,730 | $423 |
| Estradiol | 48 | $6,485 | $135 |
| Nitrofurantoin Mono-Macro | 12 | $441 | $37 |
2022: 3 drugs
| Myrbetriq | 23 | $30,597 | $1,330 |
| Estradiol | 43 | $5,898 | $137 |
| Nitrofurantoin Mono-Macro | 17 | $945 | $56 |
2021: 7 drugs
| Myrbetriq | 27 | $25,558 | $947 |
| Estradiol | 46 | $6,838 | $149 |
| Oxybutynin Chloride Er | 20 | $1,159 | $58 |
| Nitrofurantoin Mono-Macro | 31 | $837 | $27 |
| Loperamide | 11 | $752 | $68 |
| Sulfamethoxazole-Trimethoprim | 15 | $58 | $4 |
| Oxycodone | 13 | $41 | $3 |
2020: 4 drugs
| Myrbetriq | 31 | $20,631 | $666 |
| Estradiol | 19 | $3,365 | $177 |
| Nitrofurantoin Mono-Macro | 25 | $455 | $18 |
| Oxycodone | 14 | $56 | $4 |
2019: 2 drugs
| Myrbetriq | 13 | $6,428 | $494 |
| Nitrofurantoin Mono-Macro | 15 | $321 | $21 |
Money from drug and device companies
$192 in 2024
| 2024 | 2 | 2 | None | $192 |
| 2023 | 3 | 8 | None | $742 |
| 2022 | 2 | 6 | None | $535 |
| 2021 | 3 | 6 | None | $293 |
| 2020 | 4 | 6 | None | $329 |
| 2019 | 6 | 9 | None | $392 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | None | $170 | 1 payment
|
| Bluewind Medical | Revi | $22 | 1 payment
|
See all 2 published payments
| Boston Scientific | Meals · 2024-10-23 | None | $170 |
| Bluewind Medical | Meals · 2024-07-16 | Revi | $22 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $742
| Axonics | Axonics | $496 | 5 payments
|
| Caldera Medical | Desara | $221 | 2 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $25 | 1 payment
|
2022: $535
| Boston Scientific | General - Therapies | $432 | 5 payments
|
| Medtronic | Interstim | $103 | 1 payment
|
2021: $293
| Boston Scientific | Solyx | $260 | 4 payments
|
| Baxter Healthcare | Floseal | $19 | 1 payment
|
| Coloplast | Altis | $13 | 1 payment
|
2020: $329
| Coloplast | Altis | $277 | 3 payments
|
| Boston Scientific | Advantage Fit | $23 | 1 payment
|
| AbbVie | None | $15 | 1 payment
|
| TherapeuticsMD | Imvexxy | $15 | 1 payment
|
2019: $392
| Medtronic USA | Interstim | $132 | 1 payment
|
| Coloplast | Altis | $126 | 3 payments
|
| Boston Scientific | Solyx | $72 | 1 payment
|
| TherapeuticsMD | Imvexxy | $26 | 2 payments
|
| ConvaTec | Catheter | $21 | 1 payment
|
| Mission Pharmacal | Uribel | $16 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1891175436
- Licence
- NJ 25MA10545100, TX BP10052645New Jersey 25MA10545100: InactiveTexas BP10052645: Permit Terminated
- Group
- County of Santa Clara · Multicare Health System
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207VF0040X (207VF0040X); Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 1213 Walnut St Apt 508, Philadelphia, PA, 19107
- NPI first listed
- 2015-06-08
- NPI last updated
- 2019-06-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 301 University Blvd, Galveston, TX, 77555